• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的CD28反应元件对促有丝分裂反应的功能差异。

Functional disparity of distinct CD28 response elements toward mitogenic responses.

作者信息

Civil A, Rensink I, Aarden L A, Verweij C L

机构信息

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Department of Autoimmune Diseases, 1066 CX Amsterdam, The Netherlands.

出版信息

J Biol Chem. 1999 Nov 26;274(48):34369-74. doi: 10.1074/jbc.274.48.34369.

DOI:10.1074/jbc.274.48.34369
PMID:10567414
Abstract

Activation of T cells through the antigen-specific T-cell receptor in combination with a costimulatory signal results in efficient cytokine gene transcription. The CD28-induced signal represents a major costimulatory signal for T cells. A CD28 response element, named CD28RE, was first identified in the interleukin-2 (IL-2) promoter region. Here we demonstrate that the NF-kappaB sequence in the IL-6 promoter functions as a CD28 response element. Mutations in this sequence rendered the IL-6 promoter unresponsive to CD28 costimulation. Moreover, this element could replace the IL-2 CD28RE in conferring CD28 responsiveness to the IL-2 promoter. In analogy to the known CD28 response elements IL-2 CD28RE, IL-8 CD28RE, and the human immunodeficiency virus-1 (HIV-1) NF-kappaB motif, the IL-6 NF-kappaB motif efficiently bound c-Rel, c-Rel/NFKB1, and the recently identified inducible T-cell factor NF-MATp35. However, the IL-6 NF-kappaB sequence together with the IL-8 CD28RE and HIV-1 NF-kappaB sequence differed from the IL-2 CD28RE in the binding of NF-kappaB/Rel family proteins. Although the IL-2 CD28RE exerted selective binding with c-Rel and c-Rel/NFKB1, the other CD28REs allowed efficient binding of a wide range of NF-kappaB/Rel family proteins. The difference in binding specificity correlated with the capacity of the distinct CD28 response elements to function in the context of the IL-6 promoter in response to T-cell activation. Domain swapping experiments revealed that the IL-8 CD28RE and HIV-1 NF-kappaB motif conferred similar responsiveness as the genuine IL-6 NF-kappaB motif in the transcriptional activation of the IL-6 promoter upon CD28 costimulation. In contrast, replacement of the IL-6 NF-kappaB sequence by the IL-2 CD28RE motif strongly reduced the responsiveness of the IL-6 promoter. These data indicate that despite the sequence similarity, two different classes of CD28 responsive elements exist that differ in their NF-kappaB binding capacity and the ability to confer CD28 costimulatory responsiveness toward a heterologous promoter.

摘要

通过抗原特异性T细胞受体并结合共刺激信号激活T细胞,可导致有效的细胞因子基因转录。CD28诱导的信号是T细胞的主要共刺激信号。一个名为CD28RE的CD28反应元件首先在白细胞介素-2(IL-2)启动子区域被鉴定出来。在此我们证明,IL-6启动子中的NF-κB序列作为一个CD28反应元件发挥作用。该序列中的突变使IL-6启动子对CD28共刺激无反应。此外,这个元件可以取代IL-2 CD28RE,赋予IL-2启动子对CD28的反应性。与已知的CD28反应元件IL-2 CD28RE、IL-8 CD28RE以及人类免疫缺陷病毒-1(HIV-1)NF-κB基序类似,IL-6 NF-κB基序能有效结合c-Rel、c-Rel/NFKB1以及最近鉴定出的诱导性T细胞因子NF-MATp35。然而,IL-6 NF-κB序列与IL-8 CD28RE和HIV-1 NF-κB序列在NF-κB/Rel家族蛋白的结合上与IL-2 CD28RE不同。虽然IL-2 CD28RE与c-Rel和c-Rel/NFKB1有选择性结合,但其他CD28RE允许广泛的NF-κB/Rel家族蛋白有效结合。结合特异性的差异与不同的CD28反应元件在T细胞激活时在IL-6启动子背景下发挥作用的能力相关。结构域交换实验表明,在CD28共刺激时,IL-8 CD28RE和HIV-1 NF-κB基序在IL-6启动子的转录激活中赋予与真正的IL-6 NF-κB基序相似的反应性。相反,用IL-2 CD28RE基序取代IL-6 NF-κB序列会强烈降低IL-6启动子的反应性。这些数据表明,尽管序列相似,但存在两类不同的CD28反应元件,它们在NF-κB结合能力以及赋予异源启动子对CD28共刺激反应性的能力方面存在差异。

相似文献

1
Functional disparity of distinct CD28 response elements toward mitogenic responses.不同的CD28反应元件对促有丝分裂反应的功能差异。
J Biol Chem. 1999 Nov 26;274(48):34369-74. doi: 10.1074/jbc.274.48.34369.
2
RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.RelA是白细胞介素2启动子内CD28反应元件的一种强效转录激活因子。
Mol Cell Biol. 1995 Aug;15(8):4260-71. doi: 10.1128/MCB.15.8.4260.
3
Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.NF-ATp和多种NF-κB/Rel转录因子对白细胞介素-2 CD28反应元件的调控
Mol Cell Biol. 1997 May;17(5):2605-14. doi: 10.1128/MCB.17.5.2605.
4
Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.Rel、Fos和Jun蛋白参与人T细胞中与白细胞介素-2启动子CD28反应元件/激活蛋白-1序列的结合活性。
J Immunol. 1997 Aug 1;159(3):1319-27.
5
Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production.
J Biol Chem. 1996 Apr 5;271(14):8321-7. doi: 10.1074/jbc.271.14.8321.
6
CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers.CD28介导一种强大的共刺激信号,促使IkappaBbeta快速降解,这与多种NF-kappaB/Rel异二聚体的加速激活相关。
Mol Cell Biol. 1996 Dec;16(12):6736-43. doi: 10.1128/MCB.16.12.6736.
7
NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.核因子κB诱导激酶通过c-Rel的磷酸化及其反式激活活性的调节参与CD28反应元件的激活。
J Immunol. 2006 Apr 15;176(8):4666-74. doi: 10.4049/jimmunol.176.8.4666.
8
Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element.经由T细胞表面分子CD28对白细胞介素-2基因转录的激活是通过一个类核因子-κB反应元件介导的。
J Biol Chem. 1991 Aug 5;266(22):14179-82.
9
CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.CD28通过一个包含CD28反应元件(CD28RE)和核因子IL-2B AP-1位点的复合元件介导白细胞介素-2(IL-2)启动子的转录上调。
Mol Cell Biol. 1997 Jul;17(7):4051-8. doi: 10.1128/MCB.17.7.4051.
10
HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.HIV-1反式激活因子通过与白细胞介素-2启动子的CD28反应元件/激活蛋白-1复合元件结合的协同Rel/AP1复合物的定性和定量改变来抑制白细胞介素-2基因转录。
J Immunol. 2001 Apr 1;166(7):4560-9. doi: 10.4049/jimmunol.166.7.4560.

引用本文的文献

1
Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.宿主 T 细胞去分化作用驱动 HIV-1 潜伏期稳定性。
J Virol. 2022 Mar 9;96(5):e0197421. doi: 10.1128/jvi.01974-21. Epub 2022 Jan 12.
2
Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.激酶对潜伏性HIV-1感染的控制:PIM-1激酶是HIV-1重新激活的主要促成因素。
J Virol. 2014 Jan;88(1):364-76. doi: 10.1128/JVI.02682-13. Epub 2013 Oct 23.
3
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.
HIV-1 启动子增强子/核心元件中的一个 AP-1 结合位点控制了 HIV-1 建立潜伏感染的能力。
J Virol. 2013 Feb;87(4):2264-77. doi: 10.1128/JVI.01594-12. Epub 2012 Dec 12.
4
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.激酶控制可防止 HIV-1 重新激活,尽管诱导的 NF-κB 活性水平很高。
J Virol. 2012 Apr;86(8):4548-58. doi: 10.1128/JVI.06726-11. Epub 2012 Feb 15.
5
T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.Nod2在促进对刚地弓形虫1型免疫中的T细胞内在作用。
Nat Immunol. 2009 Dec;10(12):1267-74. doi: 10.1038/ni.1816. Epub 2009 Nov 1.
6
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters.CD28发出一种独特信号,导致RelA和p52核因子-κB亚基选择性募集至白细胞介素-8和Bcl-xL基因启动子上。
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6098-103. doi: 10.1073/pnas.0308688101. Epub 2004 Apr 12.
7
Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.爱泼斯坦-巴尔病毒潜伏膜蛋白1和活化的CD40受体通过核因子κB依赖性激活抗凋亡基因bfl-1
J Virol. 2004 Feb;78(4):1800-16. doi: 10.1128/jvi.78.4.1800-1816.2004.
8
Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.由CREB/ATF和AP-1家族激活的新型CD28反应性增强子,位于人类白细胞介素-2受体α链基因座中。
Mol Cell Biol. 2001 Jul;21(14):4515-27. doi: 10.1128/MCB.21.14.4515-4527.2001.